Stay updated on Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Sign up to get notified when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.

Latest updates to the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page
- Check4 days agoChange DetectedA new revision entry v3.5.3 was added to the Record History, and the previous revision v3.5.2 was removed. This updates the version history to reflect the latest revision of the study record.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.2 is now listed, replacing v3.5.0, indicating a minor version update to the page history.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page's revision metadata was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.3 was added to the history. Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Revision: v3.4.2 to the study record history. Removed the government-funding notice and Revision: v3.4.1 entry.SummaryDifference0.6%

- Check90 days agoChange DetectedA government funding lapse notice was added to the page, warning that data may not be up to date, and the revision version was updated from v3.4.0 to v3.4.1.SummaryDifference0.6%

Stay in the know with updates to Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.